Sotera Health Company(NASDAQ:SHC)

Sotera Health Company provides sterilization, and lab testing and advisory services to the medical device, pharmaceutical, and food products industries in the Americas, Europe and Asia. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs c...
Website: http://soterahealth.com
Founded: 2015
Full Time Employees: 2,900
CEO: Michael B. Petras
Sector: Healthcare
Industry: Diagnostics & Research
Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
| Unit: USD | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
revenues: | ||||||||||||||||||||||
service | 241,608,000 | 259,043,000 | 255,529,000 | 257,244,000 | 223,940,000 | 238,795,000 | 238,790,000 | 237,756,000 | 226,481,000 | 237,918,000 | 227,120,000 | 226,050,000 | 214,510,000 | 220,377,000 | 216,704,000 | 221,529,000 | 206,218,000 | 207,594,000 | 200,499,000 | 208,710,000 | 188,698,000 | |
product | 38,437,000 | 44,398,000 | 55,783,000 | 37,097,000 | 30,583,000 | 51,408,000 | 46,678,000 | 38,838,000 | 21,695,000 | 72,321,000 | 36,057,000 | 29,232,000 | 6,080,000 | 31,213,000 | 32,000,000 | 45,110,000 | 30,536,000 | 33,655,000 | 25,665,000 | 43,207,000 | 23,450,000 | |
total net revenues | 280,045,000 | 303,441,000 | 311,312,000 | 294,341,000 | 254,523,000 | 290,203,000 | 285,468,000 | 276,594,000 | 248,176,000 | 310,239,000 | 263,177,000 | 255,282,000 | 220,590,000 | 251,590,000 | 248,704,000 | 266,639,000 | 236,754,000 | 241,249,000 | 226,164,000 | 251,917,000 | 212,148,000 | |
cost of revenues: | ||||||||||||||||||||||
total cost of revenues | 132,976,000 | 137,521,000 | 133,751,000 | 127,720,000 | 119,091,000 | 125,838,000 | 127,444,000 | 123,803,000 | 121,061,000 | 130,156,000 | 117,193,000 | 115,694,000 | 109,087,000 | 109,870,000 | 112,691,000 | 116,243,000 | 107,879,000 | 107,296,000 | 100,578,000 | 108,156,000 | 96,776,000 | |
gross profit | 147,069,000 | 165,920,000 | 177,561,000 | 166,621,000 | 135,432,000 | 164,365,000 | 158,024,000 | 152,791,000 | 127,115,000 | 180,083,000 | 145,984,000 | 139,588,000 | 111,503,000 | 141,720,000 | 136,013,000 | 150,396,000 | 128,875,000 | 133,953,000 | 125,586,000 | 143,761,000 | 115,372,000 | |
yoy | 8.59% | 0.95% | 12.36% | 9.05% | 6.54% | -8.73% | 8.25% | 9.46% | 14.00% | 27.07% | 7.33% | -7.19% | -13.48% | 5.80% | 8.30% | 4.62% | 11.70% | |||||
qoq | -11.36% | -6.56% | 6.57% | 23.03% | -17.60% | 4.01% | 3.42% | 20.20% | -29.41% | 23.36% | 4.58% | 25.19% | -21.32% | 4.20% | -9.56% | 16.70% | -3.79% | 6.66% | -12.64% | 24.61% | ||
selling, general and administrative expenses | 68,211,000 | 57,514,000 | 63,294,000 | 68,893,000 | 63,061,000 | 61,837,000 | 62,009,000 | 60,575,000 | 58,209,000 | 60,358,000 | 54,112,000 | 60,287,000 | 61,910,000 | 65,949,000 | 57,091,000 | 63,132,000 | 59,542,000 | 51,827,000 | 44,038,000 | 49,828,000 | 52,465,000 | |
amortization of intangible assets | 3,031,000 | 3,023,000 | 3,090,000 | 9,298,000 | 15,327,000 | 15,382,000 | 15,508,000 | 15,417,000 | 15,732,000 | 15,701,000 | 15,774,000 | 16,097,000 | 16,227,000 | 15,603,000 | 15,727,000 | 15,769,000 | 15,841,000 | 15,700,000 | 15,877,000 | 15,661,000 | 16,543,000 | |
illinois eo litigation settlement | 30,943,000 | |||||||||||||||||||||
interest expense | 34,745,000 | 35,048,000 | 39,147,000 | 40,651,000 | 40,876,000 | 40,960,000 | 41,572,000 | 40,388,000 | 41,771,000 | 42,653,000 | 40,627,000 | 30,728,000 | 28,870,000 | 32,269,000 | 23,427,000 | 14,044,000 | 10,404,000 | 15,607,000 | 18,140,000 | 19,163,000 | 21,282,000 | |
foreign exchange loss | -571,000 | 627,000 | 289,000 | 2,436,000 | -1,054,000 | -611,000 | -572,000 | -227,000 | -426,000 | 465,000 | 347,000 | 647,000 | -535,000 | -755,000 | 788,000 | -65,000 | 756,000 | 76,000 | 578,000 | |||
other income | -960,000 | -2,016,000 | -464,000 | -5,825,000 | -1,520,000 | -1,253,000 | -2,246,000 | -1,713,000 | -2,967,000 | -7,854,000 | -693,000 | -2,764,000 | ||||||||||
income before income taxes | 42,613,000 | 70,497,000 | 72,935,000 | 18,897,000 | -14,823,000 | 44,964,000 | 42,754,000 | 15,142,000 | 11,014,000 | 65,670,000 | 470,000 | 34,485,000 | 5,402,000 | -378,502,000 | 42,016,000 | 48,108,000 | 45,267,000 | 58,734,000 | 41,103,000 | 61,797,000 | 14,082,000 | |
provision for income taxes | 16,024,000 | 35,650,000 | 24,535,000 | 10,935,000 | -1,563,000 | 32,641,000 | 25,756,000 | 6,388,000 | 4,691,000 | 26,989,000 | 14,130,000 | 10,972,000 | 2,560,000 | -58,783,000 | 16,926,000 | 17,690,000 | 14,626,000 | 22,737,000 | 13,659,000 | 19,182,000 | 3,017,000 | |
net income | 26,589,000 | 34,847,000 | 48,400,000 | 7,962,000 | -13,260,000 | 12,323,000 | 16,998,000 | 8,754,000 | 6,323,000 | 38,681,000 | -13,660,000 | 23,513,000 | 2,842,000 | -319,719,000 | 25,090,000 | 30,418,000 | 30,641,000 | 35,997,000 | 27,444,000 | 42,615,000 | 11,065,000 | |
yoy | -300.52% | 182.78% | 184.74% | -9.05% | -309.71% | -68.14% | -224.44% | -62.77% | 122.48% | -112.10% | -154.44% | -22.70% | -90.72% | -988.18% | -8.58% | -28.62% | 176.92% | |||||
qoq | -23.70% | -28.00% | 507.89% | -160.05% | -207.60% | -27.50% | 94.17% | 38.45% | -83.65% | -383.17% | -158.10% | 727.34% | -100.89% | -1374.29% | -17.52% | -0.73% | -14.88% | 31.17% | -35.60% | 285.13% | ||
other comprehensive income net of tax: | ||||||||||||||||||||||
pension and post-retirement benefits | -104,000 | 2,317,000 | -12,000 | 71,000 | 10,000 | 8,456,000 | -137,000 | 30,000 | 113,000 | -10,347,000 | -126,000 | 18,000 | -51,000 | 19,467,000 | 1,065,000 | 532,000 | -274,000 | 25,849,000 | 1,383,000 | -421,000 | -249,000 | |
interest rate derivatives | 1,633,000 | -164,000 | -29,000 | -1,123,000 | -772,000 | 662,000 | -4,016,000 | -2,461,000 | 419,000 | -8,734,000 | -1,714,000 | 4,002,000 | -9,251,000 | 2,174,000 | 9,408,000 | 3,178,000 | 6,179,000 | |||||
foreign currency translation | -17,631,000 | 13,516,000 | -17,178,000 | 82,217,000 | 19,560,000 | -92,750,000 | 24,931,000 | -23,110,000 | -27,706,000 | 40,539,000 | -32,996,000 | 21,374,000 | 11,257,000 | 35,707,000 | -69,460,000 | -46,038,000 | 14,975,000 | -3,867,000 | -29,867,000 | 20,425,000 | -3,086,000 | |
comprehensive income | 10,487,000 | 50,516,000 | 31,181,000 | 89,127,000 | 5,538,000 | -71,309,000 | 37,776,000 | -16,787,000 | -20,851,000 | 60,139,000 | -48,496,000 | 48,907,000 | 4,797,000 | -262,371,000 | -33,897,000 | -11,910,000 | 51,521,000 | 58,383,000 | -1,040,000 | 62,619,000 | 7,730,000 | |
earnings per share: | ||||||||||||||||||||||
basic | 0.09 | 0.12 | 0.17 | 0.03 | -0.05 | 0.05 | 0.06 | 0.03 | 0.02 | 0.14 | -0.05 | 0.08 | 0.01 | -1.14 | 0.09 | 0.11 | 0.11 | 0.12 | 0.1 | 0.15 | 0.04 | |
diluted | 0.09 | 0.12 | 0.17 | 0.03 | -0.05 | 0.05 | 0.06 | 0.03 | 0.02 | 0.14 | -0.05 | 0.08 | 0.01 | -1.14 | 0.09 | 0.11 | 0.11 | 0.12 | 0.1 | 0.15 | 0.04 | |
weighted-average number of shares outstanding: | ||||||||||||||||||||||
basic | 284,887 | 283,956 | 284,067 | 283,933 | 283,558 | 282,784 | 283,059 | 282,894 | 281,913 | 281,008 | 281,105 | 280,893 | 280,691 | 280,096 | 280,142 | 279,990 | 279,829 | 279,228 | 279,381 | 279,078 | 278,827 | |
diluted | 287,622 | 286,421 | 286,745 | 285,756 | 283,558 | 284,906 | 285,564 | 284,541 | 284,062 | 283,222 | 281,105 | 283,147 | 282,977 | 280,096 | 280,172 | 280,171 | 279,908 | 279,382 | 279,560 | 279,214 | 278,968 | |
illinois eo litigation settlements | 34,000,000 | |||||||||||||||||||||
loss on refinancing of debt | 295,000 | 1,087,000 | 80,000 | 8,000 | 70,000 | 23,400,000 | ||||||||||||||||
foreign exchange gain | -153,000 | -1,528,000 | ||||||||||||||||||||
other expense | -241,000 | -1,021,000 | -2,835,000 | 961,000 | -825,000 | 427,000 | -2,474,000 | 485,000 | -3,890,000 | |||||||||||||
operating expenses: | ||||||||||||||||||||||
total operating expenses | 77,219,000 | 77,517,000 | 75,992,000 | 73,941,000 | 76,059,000 | 69,886,000 | 76,384,000 | 78,137,000 | 81,552,000 | 72,818,000 | 78,901,000 | 75,383,000 | 67,527,000 | 59,915,000 | 65,489,000 | 69,008,000 | ||||||
operating income | 87,146,000 | 80,507,000 | 76,799,000 | 53,174,000 | 104,024,000 | 76,098,000 | 63,204,000 | 33,366,000 | 60,168,000 | 63,195,000 | 71,495,000 | 53,492,000 | 66,426,000 | 65,671,000 | 78,272,000 | 46,364,000 | ||||||
yoy | -16.23% | 5.79% | 21.51% | 59.37% | 72.89% | 20.42% | -11.60% | -37.62% | -9.42% | -3.77% | -8.66% | 15.37% | ||||||||||
qoq | 8.25% | 4.83% | 44.43% | -48.88% | 36.70% | 20.40% | 89.43% | -44.55% | -4.79% | -11.61% | 33.66% | -19.47% | 1.15% | -16.10% | 68.82% | |||||||
georgia eo litigation settlement | 35,000,000 | |||||||||||||||||||||
impairment of investment in unconsolidated affiliate | 9,613,000 | |||||||||||||||||||||
loss on extinguishment of debt | 4,000 | 6,365,000 | 14,312,000 | |||||||||||||||||||
less: net income attributable to noncontrolling interests | 16,000 | 223,000 | ||||||||||||||||||||
net income attributable to sotera health company | -319,719,000 | 25,090,000 | 30,418,000 | 30,641,000 | 35,997,000 | 27,444,000 | 42,599,000 | 10,842,000 | ||||||||||||||
less: comprehensive income attributable to noncontrolling interests | 326,000 | 208,000 | ||||||||||||||||||||
comprehensive income attributable to sotera health company | -262,371,000 | -33,897,000 | -11,910,000 | 51,521,000 | 58,383,000 | -1,040,000 | 62,293,000 | 7,522,000 | ||||||||||||||
interest rate swaps |
Balance Sheets:
Quarterly
Annual
| Unit: USD | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
assets | ||||||||||||||||||||||
current assets: | ||||||||||||||||||||||
cash and cash equivalents | 314,147,000 | 344,621,000 | 299,192,000 | 332,437,000 | 304,390,000 | 277,242,000 | 306,738,000 | 246,084,000 | 261,133,000 | 296,407,000 | 244,959,000 | 262,700,000 | 647,948,000 | 395,214,000 | 163,975,000 | 139,564,000 | 121,440,000 | 106,917,000 | 114,912,000 | 156,217,000 | 108,009,000 | 102,447,000 |
restricted cash short-term | 1,798,000 | 1,835,000 | 1,834,000 | 1,835,000 | 1,691,000 | 1,623,000 | 1,744,000 | 1,674,000 | 1,687,000 | 5,247,000 | 7,575,000 | 7,790,000 | 12,232,000 | 1,080,000 | 986,000 | 1,054,000 | 6,000 | 7,000 | 7,000 | 7,000 | 7,000 | 7,000 |
accounts receivable | 137,256,000 | 139,329,000 | 142,390,000 | 136,557,000 | 128,066,000 | 140,327,000 | 130,121,000 | 123,659,000 | 111,069,000 | 147,696,000 | 118,396,000 | 117,307,000 | 109,163,000 | 118,482,000 | 111,613,000 | 119,852,000 | 114,763,000 | 108,183,000 | 96,094,000 | 118,405,000 | 96,393,000 | 91,735,000 |
inventories | 57,494,000 | 54,375,000 | 49,865,000 | 59,949,000 | 61,045,000 | 49,158,000 | 53,647,000 | 57,872,000 | 51,342,000 | 48,316,000 | 37,924,000 | 42,102,000 | 46,736,000 | 37,145,000 | 37,153,000 | 39,652,000 | 45,701,000 | 54,288,000 | 37,496,000 | 35,721,000 | 33,375,000 | 34,093,000 |
prepaid expenses and other current assets | 68,969,000 | 65,250,000 | 72,351,000 | 66,024,000 | 54,663,000 | 51,031,000 | 57,421,000 | 56,652,000 | 53,663,000 | 53,846,000 | 84,201,000 | 90,910,000 | 87,303,000 | 80,995,000 | 81,673,000 | 81,173,000 | 83,956,000 | 71,923,000 | 67,707,000 | 67,942,000 | 69,758,000 | 64,964,000 |
income taxes receivable | 6,307,000 | 8,000,000 | 12,183,000 | 11,373,000 | 5,135,000 | 6,656,000 | 13,942,000 | 11,736,000 | 8,285,000 | 5,732,000 | 26,591,000 | 25,883,000 | 20,417,000 | 12,094,000 | 25,334,000 | 17,386,000 | 5,694,000 | 4,643,000 | 21,089,000 | 22,813,000 | 20,825,000 | 21,769,000 |
total current assets | 585,971,000 | 613,410,000 | 577,815,000 | 608,175,000 | 554,990,000 | 526,037,000 | 563,613,000 | 497,677,000 | 487,179,000 | 557,244,000 | 519,646,000 | 546,692,000 | 923,799,000 | 645,010,000 | 420,734,000 | 398,681,000 | 371,560,000 | 345,961,000 | 337,305,000 | 401,105,000 | 328,367,000 | 315,015,000 |
property, plant, and equipment | 1,143,452,000 | 1,130,564,000 | 1,093,972,000 | 1,080,399,000 | 1,046,449,000 | 1,036,892,000 | 1,026,028,000 | 994,614,000 | 979,422,000 | 946,914,000 | 884,385,000 | 859,138,000 | 816,164,000 | 774,527,000 | 704,406,000 | 699,571,000 | 669,161,000 | 650,797,000 | 624,341,000 | 623,513,000 | 611,620,000 | 609,814,000 |
operating lease assets | 32,896,000 | 33,393,000 | 34,427,000 | 31,524,000 | 27,072,000 | 27,551,000 | 29,266,000 | 24,272,000 | 22,517,000 | 24,037,000 | 24,672,000 | 25,179,000 | 24,941,000 | 26,481,000 | 27,194,000 | 29,853,000 | 36,984,000 | 39,946,000 | 42,682,000 | 45,147,000 | 47,117,000 | 45,963,000 |
deferred income taxes | 3,769,000 | 3,853,000 | 3,224,000 | 4,466,000 | 2,979,000 | 2,865,000 | 4,946,000 | 4,749,000 | 4,883,000 | 4,993,000 | 4,043,000 | 4,157,000 | 4,165,000 | 4,101,000 | 5,087,000 | 5,425,000 | 5,769,000 | 5,885,000 | 8,015,000 | 8,194,000 | 8,088,000 | 8,424,000 |
post-retirement assets | 54,953,000 | 53,817,000 | 49,287,000 | 48,272,000 | 44,262,000 | 42,524,000 | 32,916,000 | 30,721,000 | 29,502,000 | 28,482,000 | 39,342,000 | 39,004,000 | 36,915,000 | 35,570,000 | 9,856,000 | 8,788,000 | ||||||
other assets | 37,866,000 | 36,694,000 | 37,606,000 | 39,282,000 | 37,094,000 | 37,053,000 | 35,436,000 | 39,541,000 | 42,881,000 | 41,242,000 | 34,563,000 | 34,082,000 | 32,909,000 | 38,983,000 | 47,131,000 | 38,308,000 | 27,488,000 | 12,866,000 | 9,211,000 | 8,834,000 | 9,281,000 | 9,304,000 |
other intangible assets | 279,357,000 | 288,227,000 | 290,856,000 | 300,109,000 | 300,300,000 | 317,653,000 | 351,977,000 | 367,938,000 | 390,457,000 | 416,318,000 | 429,112,000 | 456,120,000 | 471,860,000 | 491,265,000 | 503,755,000 | 543,057,000 | 582,144,000 | 598,844,000 | 608,641,000 | 640,787,000 | 656,572,000 | 643,366,000 |
goodwill | 1,097,634,000 | 1,103,232,000 | 1,098,975,000 | 1,104,502,000 | 1,084,382,000 | 1,081,073,000 | 1,104,555,000 | 1,098,306,000 | 1,102,851,000 | 1,111,190,000 | 1,100,811,000 | 1,110,498,000 | 1,103,420,000 | 1,101,768,000 | 1,092,469,000 | 1,116,002,000 | 1,125,828,000 | 1,120,320,000 | 1,103,148,000 | 1,114,176,000 | 1,106,728,000 | 1,115,936,000 |
total assets | 3,235,898,000 | 3,263,190,000 | 3,186,162,000 | 3,216,729,000 | 3,097,528,000 | 3,071,648,000 | 3,148,737,000 | 3,057,818,000 | 3,059,692,000 | 3,130,420,000 | 3,036,574,000 | 3,074,870,000 | 3,414,173,000 | 3,117,705,000 | 2,810,632,000 | 2,839,685,000 | 2,835,769,000 | 2,789,502,000 | 2,742,739,000 | 2,851,129,000 | 2,777,000,000 | 2,761,279,000 |
liabilities and equity | ||||||||||||||||||||||
current liabilities: | ||||||||||||||||||||||
accounts payable | 76,688,000 | 77,963,000 | 61,388,000 | 63,660,000 | 70,106,000 | 55,098,000 | 70,754,000 | 64,487,000 | 61,576,000 | 71,039,000 | 57,125,000 | 55,580,000 | 61,939,000 | 74,139,000 | 60,730,000 | 65,271,000 | 55,221,000 | 72,868,000 | 51,814,000 | 63,147,000 | 57,174,000 | 52,400,000 |
accrued liabilities | 85,629,000 | 124,736,000 | 139,733,000 | 143,542,000 | 113,803,000 | 90,463,000 | 82,885,000 | 69,054,000 | 61,774,000 | 122,471,000 | 106,371,000 | 103,450,000 | 496,791,000 | 490,130,000 | 56,762,000 | 52,658,000 | 60,459,000 | 61,861,000 | 54,497,000 | 57,165,000 | 56,373,000 | 60,518,000 |
deferred revenue | 13,741,000 | 17,999,000 | 14,060,000 | 13,754,000 | 15,100,000 | 10,653,000 | 12,882,000 | 13,492,000 | 12,712,000 | 15,161,000 | 12,140,000 | 5,347,000 | 12,928,000 | 8,669,000 | 4,866,000 | 5,539,000 | 5,958,000 | 6,056,000 | ||||
current portion of long-term debt | 13,983,000 | 13,973,000 | 13,964,000 | 14,820,000 | 14,811,000 | 14,803,000 | 14,795,000 | 11,092,000 | 4,808,000 | 4,797,000 | 5,235,000 | 5,225,000 | 4,031,000 | 197,119,000 | ||||||||
current portion of finance lease obligations | 3,577,000 | 3,465,000 | 3,347,000 | 3,237,000 | 3,039,000 | 2,923,000 | 2,822,000 | 2,767,000 | 1,490,000 | 8,771,000 | 8,398,000 | 8,605,000 | 8,588,000 | 1,722,000 | 1,591,000 | 1,615,000 | 1,342,000 | 1,160,000 | 1,339,000 | 1,103,000 | 1,108,000 | 1,173,000 |
current portion of operating lease obligations | 5,788,000 | 5,755,000 | 5,589,000 | 5,598,000 | 5,084,000 | 5,056,000 | 5,287,000 | 4,835,000 | 5,303,000 | 5,934,000 | 6,362,000 | 7,111,000 | 6,942,000 | 7,554,000 | 7,718,000 | 8,132,000 | 8,906,000 | 9,289,000 | 9,546,000 | 10,106,000 | 9,631,000 | 9,383,000 |
income taxes payable | 8,398,000 | 5,693,000 | 4,318,000 | 3,937,000 | 5,394,000 | 7,559,000 | 8,341,000 | 4,409,000 | 4,507,000 | 4,150,000 | 4,139,000 | 5,726,000 | 4,589,000 | 5,867,000 | 7,351,000 | 6,876,000 | 4,368,000 | 6,695,000 | 10,914,000 | 11,072,000 | 7,384,000 | 10,448,000 |
total current liabilities | 207,804,000 | 249,584,000 | 242,399,000 | 246,320,000 | 225,991,000 | 191,002,000 | 195,537,000 | 169,633,000 | 152,340,000 | 230,654,000 | 200,594,000 | 200,330,000 | 600,149,000 | 791,567,000 | 140,031,000 | 142,021,000 | 143,851,000 | 161,161,000 | 133,606,000 | 148,792,000 | 138,019,000 | 140,598,000 |
long-term debt | 2,124,327,000 | 2,126,724,000 | 2,128,996,000 | 2,202,651,000 | 2,205,355,000 | 2,208,100,000 | 2,210,815,000 | 2,213,518,000 | 2,223,674,000 | 2,222,789,000 | 2,221,987,000 | 1,746,555,000 | 1,745,548,000 | 1,742,578,000 | 1,838,133,000 | |||||||
finance lease obligations, less current portion | 93,201,000 | 93,835,000 | 94,506,000 | 95,420,000 | 94,216,000 | 95,286,000 | 97,934,000 | 93,518,000 | 90,858,000 | 63,793,000 | 63,219,000 | 61,283,000 | 61,735,000 | 56,955,000 | 54,935,000 | 57,140,000 | 40,014,000 | 40,877,000 | 38,014,000 | 33,446,000 | 33,432,000 | 34,939,000 |
operating lease obligations, less current portion | 29,381,000 | 29,901,000 | 30,975,000 | 27,988,000 | 23,979,000 | 24,465,000 | 25,953,000 | 21,353,000 | 19,132,000 | 20,087,000 | 20,674,000 | 20,538,000 | 20,561,000 | 21,577,000 | 22,174,000 | 24,546,000 | 31,065,000 | 33,017,000 | 35,378,000 | 37,354,000 | 39,806,000 | 38,941,000 |
noncurrent asset retirement obligations | 53,852,000 | 53,496,000 | 52,411,000 | 52,150,000 | 50,152,000 | 49,319,000 | 49,102,000 | 48,096,000 | 48,021,000 | 47,944,000 | 44,382,000 | 44,492,000 | 43,350,000 | 42,586,000 | 43,889,000 | 42,688,000 | 42,995,000 | 41,833,000 | 46,117,000 | 46,408,000 | 45,633,000 | 45,013,000 |
deferred lease income | 16,651,000 | 17,057,000 | 16,933,000 | 17,397,000 | 16,676,000 | 16,784,000 | 17,984,000 | 17,906,000 | 18,223,000 | 18,762,000 | 18,444,000 | 19,045,000 | 18,785,000 | 18,902,000 | 18,769,000 | 20,146,000 | 20,916,000 | 20,745,000 | 20,871,000 | 21,550,000 | 21,362,000 | 21,255,000 |
post-retirement obligations | 7,983,000 | 8,123,000 | 8,124,000 | 8,302,000 | 7,905,000 | 7,863,000 | 8,223,000 | 8,184,000 | 8,235,000 | 8,439,000 | 7,760,000 | 8,008,000 | 7,858,000 | 7,910,000 | 10,485,000 | 11,198,000 | 11,608,000 | 11,464,000 | 42,544,000 | 45,638,000 | 46,959,000 | 48,223,000 |
noncurrent liabilities | 5,152,000 | 7,360,000 | 7,031,000 | 7,150,000 | 5,474,000 | 4,418,000 | 9,285,000 | 8,762,000 | 8,728,000 | 8,879,000 | 12,415,000 | 12,626,000 | 15,051,000 | 12,831,000 | 15,345,000 | 15,668,000 | 16,188,000 | 16,274,000 | 19,300,000 | 18,905,000 | 18,795,000 | 17,506,000 |
total liabilities | 2,613,393,000 | 2,657,155,000 | 2,635,691,000 | 2,705,446,000 | 2,683,437,000 | 2,666,737,000 | 2,678,574,000 | 2,635,054,000 | 2,630,300,000 | 2,686,686,000 | 2,659,103,000 | 2,656,503,000 | 3,053,048,000 | 2,767,467,000 | 2,203,903,000 | 2,203,685,000 | 2,193,639,000 | 2,203,406,000 | 2,216,970,000 | 2,327,858,000 | 2,311,256,000 | 2,306,705,000 |
see commitments and contingencies note | ||||||||||||||||||||||
equity: | ||||||||||||||||||||||
common stock, with 0.01 par value... | 2,860,000 | 2,860,000 | 2,860,000 | 2,860,000 | 2,860,000 | 2,860,000 | 2,860,000 | 2,860,000 | 2,860,000 | 2,860,000 | 2,860,000 | 2,860,000 | 2,860,000 | 2,860,000 | 2,860,000 | 2,860,000 | 2,860,000 | 2,860,000 | 2,860,000 | 2,860,000 | 2,860,000 | 2,860,000 |
preferred stock, with 0.01 par value... | ||||||||||||||||||||||
treasury stock | -12,100,000 | -17,013,000 | -18,657,000 | -19,038,000 | -20,855,000 | -23,434,000 | -24,612,000 | -24,764,000 | -26,042,000 | -27,182,000 | -28,474,000 | -28,700,000 | -29,420,000 | -29,775,000 | -32,653,000 | -32,654,000 | -33,536,000 | -33,545,000 | -34,000,000 | -34,000,000 | -34,000,000 | -34,000,000 |
additional paid-in capital | 1,263,189,000 | 1,262,119,000 | 1,258,715,000 | 1,251,089,000 | 1,244,841,000 | 1,243,778,000 | 1,238,899,000 | 1,229,428,000 | 1,220,547,000 | 1,215,178,000 | 1,210,346,000 | 1,202,972,000 | 1,195,357,000 | 1,189,622,000 | 1,186,620,000 | 1,181,995,000 | 1,177,097,000 | 1,172,593,000 | 1,171,104,000 | 1,167,566,000 | 1,169,852,000 | 1,166,412,000 |
retained deficit | -505,504,000 | -532,093,000 | -566,940,000 | -615,340,000 | -623,302,000 | -610,042,000 | -622,365,000 | -639,363,000 | -648,117,000 | -654,440,000 | -693,121,000 | -679,461,000 | -702,974,000 | -705,816,000 | -386,097,000 | -411,187,000 | -441,605,000 | -472,246,000 | -508,243,000 | -535,687,000 | -578,286,000 | -589,128,000 |
accumulated other comprehensive loss | -125,940,000 | -109,838,000 | -125,507,000 | -108,288,000 | -189,453,000 | -208,251,000 | -124,619,000 | -145,397,000 | -119,856,000 | -92,682,000 | -114,140,000 | -79,304,000 | -104,698,000 | -106,653,000 | -164,001,000 | -105,014,000 | -62,686,000 | -83,566,000 | -105,952,000 | -77,468,000 | -97,162,000 | -93,842,000 |
total equity | 622,505,000 | 606,035,000 | 550,471,000 | 511,283,000 | 414,091,000 | 404,911,000 | 470,163,000 | 422,764,000 | 429,392,000 | 443,734,000 | 377,471,000 | 418,367,000 | 361,125,000 | 350,238,000 | 606,729,000 | 636,000,000 | 642,130,000 | 586,096,000 | 525,769,000 | 523,271,000 | 465,744,000 | 454,574,000 |
total liabilities and equity | 3,235,898,000 | 3,263,190,000 | 3,186,162,000 | 3,216,729,000 | 3,097,528,000 | 3,071,648,000 | 3,148,737,000 | 3,057,818,000 | 3,059,692,000 | 3,130,420,000 | 3,036,574,000 | 3,074,870,000 | 3,414,173,000 | 3,117,705,000 | 2,810,632,000 | 2,839,685,000 | 2,835,769,000 | 2,789,502,000 | 2,742,739,000 | 2,851,129,000 | 2,777,000,000 | 2,761,279,000 |
deferred revenues | 11,526,000 | 12,989,000 | 13,840,000 | 6,863,000 | ||||||||||||||||||
long-term debt, less current portion | 2,224,611,000 | 2,222,333,000 | 1,747,115,000 | 1,744,541,000 | 1,743,534,000 | 1,837,580,000 | 1,824,789,000 | |||||||||||||||
current portion of asset retirement obligations | 252,000 | 793,000 | 2,108,000 | 2,896,000 | 532,000 | 606,000 | 627,000 | 619,000 | 630,000 | 660,000 | 391,000 | 620,000 | ||||||||||
investment in unconsolidated affiliate | 9,550,000 | 9,405,000 | 9,396,000 | 9,373,000 | 9,227,000 | 13,457,000 | ||||||||||||||||
total equity attributable to sotera health company | 350,238,000 | 606,729,000 | 636,000,000 | 642,130,000 | 586,096,000 | 525,769,000 | 523,271,000 | 463,264,000 | ||||||||||||||
noncontrolling interests | 2,480,000 | 2,272,000 | ||||||||||||||||||||
post-retirement asset | 7,285,000 | 5,478,000 | ||||||||||||||||||||
mandatorily redeemable noncontrolling interest | 13,625,000 | |||||||||||||||||||||
total equity (deficit) attributable to sotera health company | 452,302,000 |
Cashflow Statements:
Quarterly
Annual
| Unit: USD | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
operating activities: | |||||||||||||||||||||
net income | 26,589,000 | 34,847,000 | 48,400,000 | 7,962,000 | -13,260,000 | 12,323,000 | 16,998,000 | 8,754,000 | 6,323,000 | 38,681,000 | -13,660,000 | 23,513,000 | 2,842,000 | -319,719,000 | 25,090,000 | 30,418,000 | 30,641,000 | 35,997,000 | 27,444,000 | 42,615,000 | 11,065,000 |
adjustments to reconcile net income to net cash from operating activities: | |||||||||||||||||||||
depreciation | 25,212,000 | 26,974,000 | 22,711,000 | 23,093,000 | 22,130,000 | 20,672,000 | 23,207,000 | 20,075,000 | 20,306,000 | 20,664,000 | 17,993,000 | 18,989,000 | 18,931,000 | 16,504,000 | 15,885,000 | 15,744,000 | 15,867,000 | 16,703,000 | 16,395,000 | 15,683,000 | 15,379,000 |
amortization of intangible assets | 5,602,000 | 5,552,000 | 5,649,000 | 11,923,000 | 18,674,000 | 19,640,000 | 19,858,000 | 19,755,000 | 20,124,000 | 20,058,000 | 20,182,000 | 20,501,000 | 20,607,000 | 19,958,000 | 20,218,000 | 21,196,000 | 20,182,000 | 21,443,000 | 21,239,000 | 21,778,000 | 22,282,000 |
deferred income taxes | 4,167,000 | 16,935,000 | 8,186,000 | -9,024,000 | -16,075,000 | 7,542,000 | 9,990,000 | -4,658,000 | -3,441,000 | 165,000 | 2,969,000 | 2,085,000 | -1,770,000 | -91,113,000 | 6,737,000 | 4,783,000 | 5,633,000 | -11,847,000 | 4,627,000 | 7,141,000 | -3,637,000 |
share-based compensation expense | 14,393,000 | 7,568,000 | 7,949,000 | 8,119,000 | 7,242,000 | 8,144,000 | 9,789,000 | 10,181,000 | 8,663,000 | 8,204,000 | 8,373,000 | 8,373,000 | 7,288,000 | 6,256,000 | 4,616,000 | 5,801,000 | 4,538,000 | 3,547,000 | 3,493,000 | 3,449,000 | |
accretion of asset retirement obligations | 673,000 | 584,000 | 601,000 | 562,000 | 574,000 | 723,000 | 637,000 | 636,000 | 642,000 | 730,000 | 556,000 | 555,000 | 572,000 | 549,000 | 527,000 | 598,000 | 520,000 | 501,000 | 598,000 | 602,000 | 551,000 |
unrealized foreign exchange loss | -2,102,000 | 1,139,000 | -10,508,000 | 13,527,000 | 5,359,000 | -12,582,000 | -5,061,000 | 3,613,000 | 802,000 | 1,626,000 | |||||||||||
unrealized loss on derivatives not designated as hedging instruments | 1,194,000 | -258,000 | 1,389,000 | -3,598,000 | 1,604,000 | 1,637,000 | 1,833,000 | -2,724,000 | 227,000 | ||||||||||||
amortization of debt issuance costs | 1,467,000 | 1,484,000 | 1,305,000 | 1,375,000 | 1,270,000 | 1,280,000 | 1,254,000 | 2,169,000 | 2,535,000 | 2,529,000 | 2,410,000 | 2,202,000 | 1,910,000 | 1,422,000 | 1,423,000 | 1,422,000 | 1,414,000 | 1,372,000 | 1,544,000 | 1,582,000 | 1,663,000 |
other | -1,656,000 | -526,000 | -1,275,000 | -1,006,000 | -1,468,000 | -1,092,000 | -1,017,000 | -2,260,000 | -998,000 | -1,827,000 | -869,000 | -1,295,000 | -1,328,000 | -880,000 | -2,066,000 | -2,054,000 | -1,989,000 | -6,554,000 | -1,933,000 | -1,398,000 | -2,843,000 |
changes in operating assets and liabilities: | |||||||||||||||||||||
accounts receivable | 891,000 | 4,495,000 | -6,428,000 | -4,546,000 | 13,630,000 | -14,026,000 | -6,019,000 | -18,308,000 | 40,569,000 | -22,026,000 | -2,247,000 | -7,674,000 | 10,223,000 | -3,997,000 | 5,363,000 | -7,534,000 | -6,387,000 | -10,608,000 | 20,853,000 | -21,620,000 | -4,134,000 |
inventories | -4,088,000 | -3,754,000 | 9,040,000 | 4,176,000 | -11,839,000 | 1,470,000 | 4,861,000 | -7,032,000 | -4,052,000 | -9,106,000 | 3,011,000 | 5,635,000 | -9,512,000 | 545,000 | -116,000 | 4,689,000 | 9,323,000 | -16,816,000 | -2,659,000 | -1,869,000 | 1,099,000 |
other current assets | -2,997,000 | 6,046,000 | -4,698,000 | -10,557,000 | -3,693,000 | 6,891,000 | 309,000 | -3,352,000 | -250,000 | 4,895,000 | 8,328,000 | -2,902,000 | -6,318,000 | 7,250,000 | -6,383,000 | 2,251,000 | -8,934,000 | -5,777,000 | 1,242,000 | 3,307,000 | -2,324,000 |
accounts payable | 2,815,000 | 7,987,000 | -8,375,000 | -6,098,000 | 11,671,000 | -7,528,000 | 2,843,000 | 5,321,000 | -7,280,000 | 12,079,000 | 2,913,000 | -10,715,000 | -9,610,000 | 14,474,000 | -3,374,000 | 2,749,000 | -12,742,000 | 20,052,000 | -15,371,000 | 8,455,000 | 6,625,000 |
accrued liabilities | -10,862,000 | -11,338,000 | 27,793,000 | -4,345,000 | -10,169,000 | 10,132,000 | 15,567,000 | 12,421,000 | -31,006,000 | 14,889,000 | -33,662,000 | 13,447,000 | 8,826,000 | 22,469,000 | 9,995,000 | -14,348,000 | 2,479,000 | 9,581,000 | -3,610,000 | 1,167,000 | -5,542,000 |
illinois eo litigation settlements | -34,000,000 | ||||||||||||||||||||
income taxes payable / receivable | 4,049,000 | 4,083,000 | -1,332,000 | -7,656,000 | -556,000 | 5,724,000 | 1,089,000 | -3,535,000 | -1,808,000 | 19,290,000 | -4,299,000 | -4,516,000 | -9,551,000 | 12,718,000 | -9,082,000 | -10,746,000 | -5,222,000 | 13,723,000 | 378,000 | 520,000 | -4,518,000 |
other liabilities | -200,000 | 439,000 | -117,000 | -98,000 | 71,000 | -3,485,000 | -180,000 | 48,000 | -176,000 | -924,000 | -297,000 | -140,000 | -372,000 | -1,106,000 | 1,957,000 | -387,000 | -81,000 | -79,000 | -195,000 | -1,608,000 | 1,513,000 |
other long-term assets | -1,712,000 | 552,000 | 720,000 | -473,000 | -587,000 | -1,756,000 | -1,854,000 | -1,008,000 | -2,224,000 | 3,933,000 | -4,529,000 | 254,000 | 104,000 | -330,000 | 167,000 | -4,085,000 | -341,000 | -4,027,000 | -334,000 | 267,000 | -282,000 |
net cash from operating activities | 29,435,000 | 103,104,000 | 71,154,000 | 57,416,000 | 55,521,000 | 55,717,000 | 97,453,000 | 61,295,000 | 9,699,000 | 113,123,000 | 41,849,000 | -336,575,000 | 33,871,000 | 101,926,000 | 67,779,000 | 58,289,000 | 49,967,000 | 66,351,000 | 80,938,000 | 78,097,000 | 56,159,000 |
capital expenditures | -25,477,000 | -42,584,000 | -29,264,000 | -33,964,000 | -6,876,000 | -72,062,000 | -33,555,000 | -43,837,000 | -19,436,000 | -64,489,000 | -52,618,000 | -49,209,000 | -31,939,000 | -73,906,000 | -38,340,000 | -36,096,000 | -35,546,000 | -41,264,000 | -16,109,000 | -23,847,000 | -20,942,000 |
free cash flows | 3,958,000 | 60,520,000 | 41,890,000 | 23,452,000 | 48,645,000 | -16,345,000 | 63,898,000 | 17,458,000 | -9,737,000 | 48,634,000 | -10,769,000 | -385,784,000 | 1,932,000 | 28,020,000 | 29,439,000 | 22,193,000 | 14,421,000 | 25,087,000 | 64,829,000 | 54,250,000 | 35,217,000 |
investing activities: | |||||||||||||||||||||
purchases of property, plant and equipment | -46,166,000 | -50,699,000 | -36,172,000 | -31,229,000 | -19,918,000 | -65,870,000 | -36,389,000 | -41,921,000 | -34,890,000 | -64,826,000 | -52,015,000 | -53,134,000 | -45,000,000 | -71,736,000 | -39,000,000 | -36,096,000 | -35,546,000 | -41,264,000 | -16,109,000 | -23,847,000 | -20,942,000 |
other investing activities | 1,038,000 | 0 | 2,837,000 | 0 | 37,000 | 0 | 37,000 | 0 | 37,000 | 0 | 37,000 | 0 | 32,000 | -2,000 | 16,000 | ||||||
net cash from investing activities | -45,128,000 | -50,699,000 | -33,335,000 | -31,229,000 | -19,881,000 | -65,870,000 | -36,352,000 | -41,921,000 | -34,853,000 | -64,826,000 | -51,978,000 | -53,134,000 | -44,968,000 | -71,738,000 | -38,966,000 | -35,709,000 | -35,483,000 | -72,263,000 | -16,596,000 | -24,455,000 | -46,519,000 |
financing activities: | |||||||||||||||||||||
payment on long-term borrowings | -3,558,000 | -3,774,000 | -3,773,000 | -2,259,350,000 | -1,250,000 | ||||||||||||||||
payments of debt issuance costs | -10,000 | -1,291,000 | -24,457,000 | 4,000 | -31,000 | -226,000 | -3,435,000 | ||||||||||||||
shares withheld for employee taxes on equity awards | -8,802,000 | -2,707,000 | -207,000 | -54,000 | -3,600,000 | ||||||||||||||||
other financing activities | -419,000 | -1,456,000 | -539,000 | -789,000 | -704,000 | 1,670,000 | -804,000 | -508,000 | -2,664,000 | 1,546,000 | -1,231,000 | -495,000 | -1,627,000 | -363,000 | -396,000 | -638,000 | -418,000 | ||||
net cash from financing activities | -12,779,000 | -8,175,000 | -77,339,000 | -6,933,000 | -8,087,000 | -6,548,000 | -2,654,000 | -29,421,000 | -11,941,000 | -3,793,000 | -3,454,000 | -710,000 | 273,916,000 | 199,244,000 | -400,000 | -634,000 | -449,000 | -1,782,000 | -103,414,000 | -8,307,000 | -3,783,000 |
effect of exchange rate changes on cash and cash equivalents | -2,039,000 | 1,200,000 | 6,274,000 | 8,937,000 | -337,000 | -12,916,000 | 2,277,000 | -5,015,000 | -1,739,000 | 4,616,000 | -4,373,000 | 729,000 | 1,067,000 | 1,901,000 | -4,070,000 | -2,774,000 | 487,000 | -301,000 | -2,233,000 | 2,873,000 | -295,000 |
net increase in cash and cash equivalents, including restricted cash | -30,511,000 | 45,430,000 | -33,246,000 | 28,191,000 | 27,216,000 | -29,617,000 | -38,834,000 | 49,120,000 | -17,956,000 | -389,690,000 | 263,886,000 | 231,333,000 | 24,343,000 | 19,172,000 | 14,522,000 | -7,995,000 | -41,305,000 | 48,208,000 | 5,562,000 | ||
cash and cash equivalents, including restricted cash, at beginning of period | 346,456,000 | 0 | 0 | 0 | 278,865,000 | 0 | 0 | 0 | 301,654,000 | 0 | 0 | 0 | 396,294,000 | 0 | 0 | 0 | 106,924,000 | 0 | 0 | 0 | 102,454,000 |
cash and cash equivalents, including restricted cash, at end of period | 315,945,000 | 45,430,000 | -33,246,000 | 28,191,000 | 306,081,000 | -29,617,000 | 60,724,000 | -15,062,000 | 262,820,000 | 49,120,000 | -17,956,000 | -389,690,000 | 660,180,000 | 231,333,000 | 24,343,000 | 19,172,000 | 121,446,000 | -7,995,000 | -41,305,000 | 48,208,000 | 108,016,000 |
supplemental disclosures of cash flow information: | |||||||||||||||||||||
cash paid during the period for interest | 36,546,000 | 34,415,000 | 26,884,000 | 55,300,000 | 47,416,000 | 37,145,000 | 31,610,000 | 41,434,000 | 69,735,000 | 23,146,000 | 72,344,000 | 42,896,000 | 35,456,000 | 10,804,000 | 22,988,000 | 26,248,000 | 15,809,000 | 5,046,000 | 17,111,000 | 16,870,000 | 19,745,000 |
cash paid during the period for income taxes, net of tax refunds received | 9,200,000 | 13,266,000 | 15,400,000 | 19,992,000 | 12,215,000 | 23,382,000 | 14,733,000 | 17,877,000 | 9,837,000 | 7,623,000 | 14,997,000 | 13,576,000 | 14,014,000 | 19,022,000 | 19,134,000 | 23,835,000 | 13,505,000 | 20,085,000 | 9,137,000 | 11,224,000 | 11,561,000 |
purchases of property, plant and equipment included in accounts payable | 20,689,000 | 8,115,000 | 6,908,000 | -2,735,000 | 13,042,000 | -6,192,000 | 2,834,000 | -1,916,000 | 15,454,000 | 337,000 | -603,000 | 3,925,000 | 13,061,000 | -2,170,000 | 660,000 | ||||||
loss on refinancing of debt | 295,000 | 1,087,000 | 8,000 | 70,000 | |||||||||||||||||
illinois eo litigation settlement | 0 | 30,943,000 | 0 | 0 | |||||||||||||||||
georgia eo litigation settlement | 0 | 0 | 0 | -35,000,000 | 0 | ||||||||||||||||
proceeds from long-term borrowings | 0 | 0 | 0 | 500,000,000 | |||||||||||||||||
payment of revolving credit facility | 0 | 0 | |||||||||||||||||||
payments of debt issuance costs and debt discount | -455,000 | -1,593,000 | -17,000 | -1,850,000 | -973,000 | ||||||||||||||||
payments of long-term borrowings | |||||||||||||||||||||
buyout of leased facility | 0 | 0 | |||||||||||||||||||
payment of long-term borrowings | |||||||||||||||||||||
buyout of leased facilities | -6,736,000 | ||||||||||||||||||||
impairment of investment in unconsolidated affiliate | 0 | 0 | |||||||||||||||||||
purchase of regulatory compliance associates inc., net of cash acquired | |||||||||||||||||||||
proceeds from revolving credit facility and long-term borrowings | |||||||||||||||||||||
unrealized foreign exchange losses | -1,156,000 | 2,430,000 | 73,000 | -382,000 | -1,257,000 | 2,354,000 | |||||||||||||||
unrealized gain on derivatives not designated as hedging instruments | -7,364,000 | ||||||||||||||||||||
net decrease in cash and cash equivalents, including restricted cash | |||||||||||||||||||||
payment on revolving credit facility | -200,000,000 | ||||||||||||||||||||
loss on extinguishment of debt | 4,000 | 6,365,000 | 0 | 14,312,000 | |||||||||||||||||
purchase of bioscience laboratories, llc, net of cash acquired | 0 | 230,000 | -608,000 | -13,152,000 | |||||||||||||||||
purchase of mandatorily redeemable noncontrolling interest in nelson laboratories fairfield, inc. | 0 | 0 | 0 | -12,425,000 | |||||||||||||||||
purchase of noncontrolling interests in china subsidiaries | 0 | -698,000 | |||||||||||||||||||
payments of debt issuance costs and prepayment premium | 0 | -74,000 | |||||||||||||||||||
adjustment to purchase of regulatory compliance associates inc. | 0 | 387,000 | 63,000 | ||||||||||||||||||
unrealized gains on derivatives not designated as hedging instruments | |||||||||||||||||||||
purchase of iotron industries canada, inc., net of cash acquired | |||||||||||||||||||||
proceeds from issuance of common stock, net of underwriting discounts and issuance costs | |||||||||||||||||||||
repurchase of common shares | |||||||||||||||||||||
payments on revolving credit facility and long-term borrowings | |||||||||||||||||||||
payments on debt | |||||||||||||||||||||
equipment purchases included in accounts payable | 9,508,000 | -3,000 | 4,857,000 | 2,281,000 | 7,389,000 | ||||||||||||||||
impairment of long-lived assets | |||||||||||||||||||||
share-based non-cash compensation expense | |||||||||||||||||||||
unrealized gain on embedded derivative instruments | |||||||||||||||||||||
dividends and distributions to shareholders | |||||||||||||||||||||
unrealized loss on embedded derivative instruments | 1,190,000 | -761,000 | -853,000 | ||||||||||||||||||
proceeds from borrowings | |||||||||||||||||||||
proceeds from revolving credit facility | |||||||||||||||||||||
payments on long-term borrowings | |||||||||||||||||||||
gain on interest rate swap | |||||||||||||||||||||
net loss | |||||||||||||||||||||
adjustments to reconcile net loss to net cash from operating activities: | |||||||||||||||||||||
net cash from (provided by) financing activities |
